# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-26-000019
Filing Date
2026-07-31
Accepted
2026-07-31 07:10:41
Documents
70
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | howl-20260630.htm iXBRL | 10-Q | 1464440
2 | EX-10.1 | a06302026ex101.htm | EX-10.1 | 360222
3 | EX-10.2 | a06302026ex102.htm | EX-10.2 | 24689
4 | EX-31.1 | a06302026ex311.htm | EX-31.1 | 10210
5 | EX-31.2 | a06302026ex312.htm | EX-31.2 | 10247
6 | EX-32.1 | a06302026ex321.htm | EX-32.1 | 6980
| Complete submission text file | 0001785530-26-000019.txt |  | 6615553

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | howl-20260630.xsd | EX-101.SCH | 41534
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | howl-20260630_cal.xml | EX-101.CAL | 49811
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | howl-20260630_def.xml | EX-101.DEF | 165822
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | howl-20260630_lab.xml | EX-101.LAB | 531601
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | howl-20260630_pre.xml | EX-101.PRE | 368899
74 | EXTRACTED XBRL INSTANCE DOCUMENT | howl-20260630_htm.xml | XML | 643923

Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 261225406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)